To include your compound in the COVID-19 Resource Center, submit it here.

FDA to discuss Sandoz biosimilar, Valeant's brodalumab

FDA scheduled advisory committee meetings to discuss BLAs for biosimilar etanercept ( GP2015) from the Sandoz unit

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE